These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20855558)

  • 1. Identification of selective enzyme inhibitors by fragment library screening.
    Gao G; Liu X; Pavlovsky A; Viola RE
    J Biomol Screen; 2010 Oct; 15(9):1042-50. PubMed ID: 20855558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cautionary tale of structure-guided inhibitor development against an essential enzyme in the aspartate-biosynthetic pathway.
    Pavlovsky AG; Thangavelu B; Bhansali P; Viola RE
    Acta Crystallogr D Biol Crystallogr; 2014 Dec; 70(Pt 12):3244-52. PubMed ID: 25478842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Fragment Library Screening Approach to Identify Selective Inhibitors against an Essential Fungal Enzyme.
    Dahal GP; Viola RE
    SLAS Discov; 2018 Jul; 23(6):520-531. PubMed ID: 29608391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of a redundant enzyme: a second isoform of aspartate beta-semialdehyde dehydrogenase in Vibrio cholerae.
    Viola RE; Liu X; Ohren JF; Faehnle CR
    Acta Crystallogr D Biol Crystallogr; 2008 Mar; 64(Pt 3):321-30. PubMed ID: 18323627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elaboration of a fragment library hit produces potent and selective aspartate semialdehyde dehydrogenase inhibitors.
    Thangavelu B; Bhansali P; Viola RE
    Bioorg Med Chem; 2015 Oct; 23(20):6622-31. PubMed ID: 26404410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular docking and enzymatic evaluation to identify selective inhibitors of aspartate semialdehyde dehydrogenase.
    Luniwal A; Wang L; Pavlovsky A; Erhardt PW; Viola RE
    Bioorg Med Chem; 2012 May; 20(9):2950-6. PubMed ID: 22464683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early stage efficacy and toxicology screening for antibiotics and enzyme inhibitors.
    Sarver JG; Trendel JA; Bearss NR; Wang L; Luniwal A; Erhardt PW; Viola RE
    J Biomol Screen; 2012 Jun; 17(5):673-82. PubMed ID: 22460173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of the aspartate beta-semialdehyde dehydrogenase family: the first structure of a fungal ortholog.
    Arachea BT; Liu X; Pavlovsky AG; Viola RE
    Acta Crystallogr D Biol Crystallogr; 2010 Feb; 66(Pt 2):205-12. PubMed ID: 20124701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization of inhibitors with selectivity against members of a homologous enzyme family.
    Pavlovsky AG; Liu X; Faehnle CR; Potente N; Viola RE
    Chem Biol Drug Des; 2012 Jan; 79(1):128-36. PubMed ID: 22039970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of conformationally restricted inhibitors of aspartate semialdehyde dehydrogenase.
    Evitt AS; Cox RJ
    Mol Biosyst; 2011 May; 7(5):1564-75. PubMed ID: 21369577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Label-free primary screening and affinity ranking of fragment libraries using parallel analysis of protein panels.
    Hämäläinen MD; Zhukov A; Ivarsson M; Fex T; Gottfries J; Karlsson R; Björsne M
    J Biomol Screen; 2008 Mar; 13(3):202-9. PubMed ID: 18270366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ultraefficient affinity-based high-throughout screening process: application to bacterial cell wall biosynthesis enzyme MurF.
    Comess KM; Schurdak ME; Voorbach MJ; Coen M; Trumbull JD; Yang H; Gao L; Tang H; Cheng X; Lerner CG; McCall JO; Burns DJ; Beutel BA
    J Biomol Screen; 2006 Oct; 11(7):743-54. PubMed ID: 16973923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for antibacterial inhibitors of the UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) using a high-throughput mass spectrometry assay.
    Langsdorf EF; Malikzay A; Lamarr WA; Daubaras D; Kravec C; Zhang R; Hart R; Monsma F; Black T; Ozbal CC; Miesel L; Lunn CA
    J Biomol Screen; 2010 Jan; 15(1):52-61. PubMed ID: 20019290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspartate semialdehyde dehydrogenase inhibition suppresses the growth of the pathogenic fungus Candida albicans.
    Dahal GP; Launder D; McKeone KMM; Hunter JP; Conti HR; Viola RE
    Drug Dev Res; 2020 Sep; 81(6):736-744. PubMed ID: 32383780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a high-throughput screening assay for stearoyl-CoA desaturase using rat liver microsomes, deuterium labeled stearoyl-CoA and mass spectrometry.
    Soulard P; McLaughlin M; Stevens J; Connolly B; Coli R; Wang L; Moore J; Kuo MS; LaMarr WA; Ozbal CC; Bhat BG
    Anal Chim Acta; 2008 Oct; 627(1):105-11. PubMed ID: 18790133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and testing of selective inactivators against an antifungal enzyme target.
    Friday SN; Cheng DW; Zagler SG; Zanella BS; Dietz JD; Calbat CN; Roach LT; Bagnal C; Faile IS; Halkides CJ; Viola RE
    Drug Dev Res; 2022 Apr; 83(2):447-460. PubMed ID: 34469014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural-functional analysis of drug target aspartate semialdehyde dehydrogenase.
    Kumar R; R R; Diwakar V; Khan N; Kumar Meghwanshi G; Garg P
    Drug Discov Today; 2024 Mar; 29(3):103908. PubMed ID: 38301800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.